OTCMKTS:REVXF Revenio Group Oyj (REVXF) Stock Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free REVXF Stock Alerts $28.35 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$28.35▼$28.3550-Day Range$28.35▼$34.8052-Week Range$28.35▼$28.35VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest Get Revenio Group Oyj alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Revenio Group Oyj Stock (OTCMKTS:REVXF)Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.Read More REVXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart REVXF Stock News HeadlinesApril 23, 2024 | americanbankingnews.comFinancial Contrast: OpGen (NASDAQ:OPGN) and Revenio Group Oyj (OTCMKTS:REVXF)March 6, 2024 | gurufocus.comQ4 2021 Revenio Group Oyj Earnings Call TranscriptApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.March 6, 2024 | gurufocus.comQ1 2022 Revenio Group Oyj Earnings Call TranscriptMarch 6, 2024 | gurufocus.comQ2 2022 Revenio Group Oyj Earnings Call TranscriptMarch 6, 2024 | gurufocus.comQ1 2023 Revenio Group Oyj Earnings Call TranscriptMarch 6, 2024 | gurufocus.comQ2 2023 Revenio Group Oyj Earnings Call TranscriptSee More Headlines Receive REVXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Revenio Group Oyj and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:REVXF CUSIPN/A CIKN/A Webwww.reveniogroup.fi Phone358 9877 51150FaxN/AEmployees207Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jouni Toijala B.Sc. (Age 56)M.B.A., President & CEO Comp: $484.47kMr. Robin Pulkkinen M.Sc. (Age 44)M.Sc. (Econ), Chief Financial Officer Mr. Ari Isomäki (Age 58)Vice President of Operations Mr. Tomi Karvo M.B.A. (Age 58)M.Sc., Vice President of Products, Brand & Marketing Mr. John Floyd (Age 54)Vice President of Sales Ms. Hanna Vuornos (Age 46)Vice President of People & Culture Kate TaylorVice President of Strategy & Business DevelopmentMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors REVXF Stock Analysis - Frequently Asked Questions Should I buy or sell Revenio Group Oyj stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Revenio Group Oyj in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" REVXF shares. View REVXF analyst ratings or view top-rated stocks. How have REVXF shares performed in 2024? Revenio Group Oyj's stock was trading at $34.80 at the beginning of 2024. Since then, REVXF stock has decreased by 18.5% and is now trading at $28.35. View the best growth stocks for 2024 here. How do I buy shares of Revenio Group Oyj? Shares of REVXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:REVXF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revenio Group Oyj Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
